The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., & Pandolfi, P. P. (2010) · Nature · doi:10.1038/nature09144 · Cited by 2,323
Identification of Mammalian microRNA Host Genes and Transcription Units
Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L., & Bradley, A. (2004) · Genome Research · doi:10.1101/gr.2722704 · Cited by 2,128
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
Calin, G. A., Liu, C.-G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C. D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404432101 · Cited by 1,285
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Varambally, S., Cao, Q., Mani, R.-S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,052
The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L., D'Urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1880 · Cited by 989
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Self-citationInactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 784
Galardi, S., Mercatelli, N., Giorda, E., Massalini, S., Frajese, G. V., Ciafre, S. A., & Farace, M. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701805200 · Cited by 749
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705
Ambs, S., Prueitt, R. L., Yi, M., Hudson, R. S., Howe, T. M., Petrocca, F., Wallace, T. A., Liu, C.-G., Volinia, S., Calin, G. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0144 · Cited by 704
Hanke, M., Hoefig, K., Merz, H., Feller, A. C., Kausch, I., Jocham, D., Warnecke, J. M., & Sczakiel, G. (2010) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.027 · Cited by 638
The Promise of MicroRNA Replacement Therapy
Bader, A. G., Brown, D., & Winkler, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2010 · Cited by 617
An E2F/miR-20a Autoregulatory Feedback Loop
Sylvestre, Y., De Guire, V., Querido, E., Mukhopadhyay, U. K., Bourdeau, V., Major, F., Ferbeyre, G., & Chartrand, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608939200 · Cited by 610
Micro-RNA profiling in kidney and bladder cancers
Gottardo, F., Liu, C. G., Ferracin, M., Calin, G. A., Fassan, M., Bassi, P., Sevignani, C., Byrne, D., Negrini, M., Pagano, F., et al. (2007) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.01.019 · Cited by 600
Circulating miRNAs are correlated with tumor progression in prostate cancer
Brase, J. C., Johannes, M., Schlomm, T., Fälth, M., Haese, A., Steuber, T., Beissbarth, T., Kuner, R., & Sültmann, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25376 · Cited by 587
Self-citationNanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
miR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells
Würdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., Soutschek, J., Weissleder, R., Breakefield, X. O., & Krichevsky, A. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.005 · Cited by 463
Takeshita, F., Patrawala, L., Osaki, M., Takahashi, R.-U., Yamamoto, Y., Kosaka, N., Kawamata, M., Kelnar, K., Bader, A. G., Brown, D., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.207 · Cited by 420
Ribas, J., Ni, X., Haffner, M., Wentzel, E. A., Salmasi, A. H., Chowdhury, W. H., Kudrolli, T. A., Yegnasubramanian, S., Luo, J., Rodriguez, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1448 · Cited by 416
Adam, L., Zhong, M., Choi, W., Qi, W., Nicoloso, M., Arora, A., Calin, G., Wang, H., Siefker-Radtke, A., McConkey, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2245 · Cited by 412
Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray
Lodes, M. J., Caraballo, M., Suciu, D., Munro, S., Kumar, A., & Anderson, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006229 · Cited by 406
Identification of novel microRNA targets based on microRNA signatures in bladder cancer
Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K., Kawahara, K., Toki, K., Kawakami, K., Nishiyama, K., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24390 · Cited by 404
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
Noonan, E. J., Place, R. F., Pookot, D., Basak, S., Whitson, J. M., Hirata, H., Giardina, C., & Dahiya, R. (2009) · Oncogene · doi:10.1038/onc.2009.19 · Cited by 396
Loss of mir-146a function in hormone-refractory prostate cancer
Lin, S.-L., Chiang, A., Chang, D., & Ying, S.-Y. (2008) · RNA · doi:10.1261/rna.874808 · Cited by 382
Friedman, J. M., Liang, G., Liu, C.-C., Wolff, E. M., Tsai, Y. C., Ye, W., Zhou, X., & Jones, P. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3114 · Cited by 382
Shi, X.-B., Xue, L., Yang, J., Ma, A.-H., Zhao, J., Xu, M., Tepper, C. G., Evans, C. P., Kung, H.-J., & deVere White, R. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706641104 · Cited by 378
Self-citationLi, T., Li, D., Sha, J., Sun, P., & Huang, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.077 · Cited by 370
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25461 · Cited by 367
Dyrskjøt, L., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A. N., Lamy, P., Ramanathan, R., Fristrup, N., Jensen, J. L., Andersen, C. L., Zieger, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4043 · Cited by 363
Gandellini, P., Folini, M., Longoni, N., Pennati, M., Binda, M., Colecchia, M., Salvioni, R., Supino, R., Moretti, R., Limonta, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2894 · Cited by 358
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Catto, J. W. F., Miah, S., Owen, H. C., Bryant, H., Myers, K., Dudziec, E., Larré, S., Milo, M., Rehman, I., Rosario, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0744 · Cited by 329
Self-citationZhang, H., Yang, L., Zhu, Y., Yao, X., Zhang, S., Dai, B., Zhu, Y., Shen, Y., Shi, G., & Ye, D. (2011) · The Prostate · doi:10.1002/pros.21246 · Cited by 322
Moltzahn, F., Olshen, A. B., Baehner, L., Peek, A., Fong, L., Stöppler, H., Simko, J., Hilton, J. F., Carroll, P., & Blelloch, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1229 · Cited by 322
MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer
Majid, S., Dar, A. A., Saini, S., Yamamura, S., Hirata, H., Tanaka, Y., Deng, G., & Dahiya, R. (2010) · Cancer · doi:10.1002/cncr.25488 · Cited by 294
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis
Saini, S., Majid, S., Yamamura, S., Tabatabai, L., Suh, S. O., Shahryari, V., Chen, Y., Deng, G., Tanaka, Y., & Dahiya, R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2619 · Cited by 275
Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L., Hijiya, N., Uchida, T., Sato, F., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2437 · Cited by 269
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
Sun, T., Wang, Q., Balk, S., Brown, M., Lee, G.-S. M., & Kantoff, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4112 · Cited by 263
miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells
Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J., & Jin, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009429 · Cited by 247
Dong, Q., Meng, P., Wang, T., Qin, W., Qin, W., Wang, F., Yuan, J., Chen, Z., Yang, A., & Wang, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010147 · Cited by 245
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
Szczyrba, J., Löprich, E., Wach, S., Jung, V., Unteregger, G., Barth, S., Grobholz, R., Wieland, W., Stöhr, R., Hartmann, A., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0443 · Cited by 227
Identification of a MicroRNA Panel for Clear-cell Kidney Cancer
Juan, D., Alexe, G., Antes, T., Liu, H., Madabhushi, A., Delisi, C., Ganesan, S., Bhanot, G., & Liou, L. S. (2010) · Urology · doi:10.1016/j.urology.2009.10.033 · Cited by 225
Veerla, S., Lindgren, D., Kvist, A., Frigyesi, A., Staaf, J., Persson, H., Liedberg, F., Chebil, G., Gudjonsson, S., Borg, Å., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24183 · Cited by 216
Oncogenic Role of miR-483-3p at the IGF2/483 Locus
Veronese, A., Lupini, L., Consiglio, J., Visone, R., Ferracin, M., Fornari, F., Zanesi, N., Alder, H., D'Elia, G., Gramantieri, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4456 · Cited by 210
MicroRNA‐125b suppresses the development of bladder cancer by targeting E2F3
Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., Dong, W., Huang, J., & Lin, T. (2011) · International Journal of Cancer · doi:10.1002/ijc.25509 · Cited by 208
Kojima, K., Fujita, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2010) · The Prostate · doi:10.1002/pros.21185 · Cited by 205
miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice
Clapé, C., Fritz, V., Henriquet, C., Apparailly, F., Fernandez, P. L., Iborra, F., Avancès, C., Villalba, M., Culine, S., & Fajas, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007542 · Cited by 198
Fujita, Y., Kojima, K., Ohhashi, R., Hamada, N., Nozawa, Y., Kitamoto, A., Sato, A., Kondo, S., Kojima, T., Deguchi, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079525 · Cited by 192
miR‐125b promotes growth of prostate cancer xenograft tumor through targeting pro‐apoptotic genes
Shi, X., Xue, L., Ma, A., Tepper, C. G., Kung, H., & White, R. W. D. (2011) · The Prostate · doi:10.1002/pros.21270 · Cited by 191
Yang, C. H., Yue, J., Fan, M., & Pfeffer, L. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2579 · Cited by 179
Weng, L., Wu, X., Gao, H., Mu, B., Li, X., Wang, J., Guo, C., Jin, J. M., Chen, Z., Covarrubias, M., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2736 · Cited by 174
Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer
Yates, D. R., Rehman, I., Abbod, M. F., Meuth, M., Cross, S. S., Linkens, D. A., Hamdy, F. C., & Catto, J. W. F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2476 · Cited by 173
Self-citationMicroRNA profiling of human kidney cancer subtypes.
Petillo, D., Kort, E., Anema, J., Furge, K., Yang, X.-M. J., & Teh, B. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000318 · Cited by 171
Radiation modulation of MicroRNA in prostate cancer cell lines
Josson, S., Sung, S., Lao, K., Chung, L. W. K., & Johnstone, P. A. S. (2008) · The Prostate · doi:10.1002/pros.20827 · Cited by 169
Androgen regulation of micro‐RNAs in prostate cancer
Waltering, K. K., Porkka, K. P., Jalava, S. E., Urbanucci, A., Kohonen, P. J., Latonen, L. M., Kallioniemi, O. P., Jenster, G., & Visakorpi, T. (2011) · The Prostate · doi:10.1002/pros.21276 · Cited by 166
Self-citationThe VHL-dependent regulation of microRNAs in renal cancer
Neal, C. S., Michael, M. Z., Rawlings, L. H., Van der Hoek, M. B., & Gleadle, J. M. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-64 · Cited by 164
miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer
Epis, M. R., Giles, K. M., Barker, A., Kendrick, T. S., & Leedman, P. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030098 · Cited by 163
The miR-17-92 Cluster is Over Expressed in and Has an Oncogenic Effect on Renal Cell Carcinoma
Chow, T.-F. F., Mankaruos, M., Scorilas, A., Youssef, Y., Girgis, A., Mossad, S., Metias, S., Rofael, Y., Honey, R. J., Stewart, R., et al. (2010) · Journal of Urology · doi:10.1016/j.juro.2009.09.086 · Cited by 163
Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer
Wang, L., Tang, H., Thayanithy, V., Subramanian, S., Oberg, A. L., Cunningham, J. M., Cerhan, J. R., Steer, C. J., & Thibodeau, S. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2183 · Cited by 163
miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions
Hagman, Z., Larne, O., Edsjö, A., Bjartell, A., Ehrnström, R. A., Ulmert, D., Lilja, H., & Ceder, Y. (2010) · International Journal of Cancer · doi:10.1002/ijc.25269 · Cited by 162
Self-citationThe functional significance of microRNA-145 in prostate cancer
Zaman, M. S., Chen, Y., Deng, G., Shahryari, V, Suh, S. O., Saini, S., Majid, S., Liu, J., Khatri, G., Tanaka, Y., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605742 · Cited by 162
miR-23b* targets proline oxidase, a novel tumor suppressor protein in renal cancer
Liu, W., Zabirnyk, O., Wang, H., Shiao, Y.-H., Nickerson, M. L., Khalil, S., Anderson, L. M., Perantoni, A. O., & Phang, J. M. (2010) · Oncogene · doi:10.1038/onc.2010.237 · Cited by 160
Murata, T., Takayama, K., Katayama, S., Urano, T., Horie‐Inoue, K., Ikeda, K., Takahashi, S., Kawazu, C., Hasegawa, A., Ouchi, Y., et al. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.32 · Cited by 154
Ylösmäki, E. O., Hakkarainen, T., Hemminki, A., Visakorpi, T., Andino, R., & Saksela, K. (2008) · Journal of Virology · doi:10.1128/jvi.01608-08 · Cited by 150
Self-citationOstenfeld, M. S., Bramsen, J. B., Lamy, P., Villadsen, S. B., Fristrup, N., Sørensen, K. D., Ulhøi, B. P., Borre, M., Kjems, J., Dyrskjøt, L., et al. (2009) · Oncogene · doi:10.1038/onc.2009.395 · Cited by 145
Majid, S., Dar, A. A., Saini, S., Chen, Y., Shahryari, V., Liu, J., Zaman, M. S., Hirata, H., Yamamura, S., Ueno, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4176 · Cited by 145
Minner, S. J. P., Jessen, B., Stiedenroth, L., Burandt, E., Köllermann, J. W., Mirlacher, M., Erbersdobler, A., Eichelberg, C., Fisch, M., Brümmendorf, T. H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2546 · Cited by 144
Self-citationmiR‐193b is an epigenetically regulated putative tumor suppressor in prostate cancer
Rauhala, H. E., Jalava, S. E., Isotalo, J., Bracken, H., Lehmusvaara, S., Tammela, T. L. J., Oja, H., & Visakorpi, T. (2010) · International Journal of Cancer · doi:10.1002/ijc.25162 · Cited by 137
Self-citationAssociation of microRNA‐34a overexpression with proliferation is cell type‐dependent
Dutta, K. K., 田中, 義., Liu, Y., Yamada, T., Akatsuka, S., Hu, Q., Yoshihara, M., Ohara, H., Takehashi, M., Shinohara, T., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00619.x · Cited by 124
The E2F3-Oncomir-1 Axis Is Activated in Wilms' Tumor
Kort, E. J., Farber, L. J., Tretiakova, M., Petillo, D., Furge, K. A., Yang, X. J., Cornelius, A. S., & Teh, B. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0592 · Cited by 122
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer
Chiyomaru, T., Enokida, H., Kawakami, K., Tatarano, S., Uchida, Y., Kawahara, K., Nishiyama, K., Seki, N., & Nakagawa, M. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.05.008 · Cited by 117
Lee, C., Rennie, P. S., & Jia, W. W.-G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0051 · Cited by 113
Li, B., Shi, X.-B., Nori, D., Chao, C., Chen, A. M., Valicenti, R. K., & White, R. D. (2010) · The Prostate · doi:10.1002/pros.21272 · Cited by 111
Dudziec, E., Miah, S., Choudhry, H., Owen, H. C., Blizard, S., Glover, M., Hamdy, F. C., & Catto, J. W. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2017 · Cited by 109
Self-citationA microRNA expression ratio defining the invasive phenotype in bladder tumors
Neely, L. A., Rieger‐Christ, K., Neto, B. S., Eroshkin, A. M., Garver, J., Patel, S. A., Phung, N. A., McLaughlin, S., Libertino, J. A., Whitney, D. H., et al. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.06.006 · Cited by 108
Microarray analysis of microRNA expression in renal clear cell carcinoma.
Huang, Y., Dai, Y., Yang, J., Chen, T.-W., Yin, Y., Tang, M., Hu, C., & Zhang, L. (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2009.04.010 · Cited by 95
Cao, Y. W., Yu, S., Wang, Y., Guo, G.-Y., Ding, Q., & An, R. (2010) · Tumor Biology · doi:10.1007/s13277-010-0111-z · Cited by 80
Catto, J. W. F., Abbod, M., Wild, P. J., Linkens, D. A., Pilarsky, C. P., Rehman, I., Rosario, D. J., Denzinger, S., Burger, M., Stoehr, R., et al. (2009) · European Urology · doi:10.1016/j.eururo.2009.10.029 · Cited by 64
Self-citationNovel ZEB1 expression in bladder tumorigenesis
Kenney, P. A., Wszolek, M. F., Rieger‐Christ, K., Neto, B. S., Gould, J. J., Harty, N. J., Mosquera, J. M., Zeheb, R., Loda, M. F., Darling, D. S., et al. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09489.x · Cited by 57
Are microRNAs located in genomic regions associated with cancer?
Lamy, P., Andersen, C. L., Dyrskjøt, L., Tørring, N., Orntoft, T. F., & Wiuf, C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603381 · Cited by 55
Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group
Wang, W.-X., Kyprianou, N., Wang, X., & Nelson, P. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1684 · Cited by 48
RNA Interference Advances to Early-Stage Clinical Trials
Brower, V. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq405 · Cited by 43
Von Hippel-Lindau Gene Product Modulates TIS11B Expression in Renal Cell Carcinoma
Sinha, S., Dutta, S. K., Datta, K., Ghosh, A. K., & Mukhopadhyay, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058065 · Cited by 36
Cited by
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
Changes in circulating microRNA levels associated with prostate cancer
Bryant, R. J., Pawlowski, T., Catto, J. W. F., Marsden, G., Vessella, R. L., Rhees, B., Kuslich, C., Visakorpi, T., & Hamdy, F. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.595 · Cited by 715
Self-citationCirc HIPK 3 sponges miR‐558 to suppress heparanase expression in bladder cancer cells
Li, Y., Zheng, F., Xiao, X., Xie, F., Tao, D., Huang, C., Liu, D., Wang, M., Wang, L., Zeng, F., et al. (2017) · EMBO reports · doi:10.15252/embr.201643581 · Cited by 557
PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction
You, Z.-H., Huang, Z.-A., Zhu, Z., Yan, G.-Y., Li, Z.-W., Wen, Z., & Chen, X. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005455 · Cited by 384
Bao, B., Wang, Z., Ali, S., Ahmad, A., Azmi, A. S., Sarkar, S. H., Banerjee, S., Kong, D., Li, Y., Thakur, S., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0299 · Cited by 337
Metadata
- Authors
- Catto, J. W. F., Alcaraz, A., Bjartell, A. S., De Vere White, R., Evans, C. P., Fussel, S., Hamdy, F. C., Kallioniemi, O., Mengual, L., Schlomm, T., & Visakorpi, T.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 59
- Issue
- 5
- Pages
- 671-681
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2157968886
- Cited by
- 469
- References
- 93
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.